Calcitonin

Revision as of 21:01, 24 August 2019 by ClaireLewis (talk | contribs) (Created page with "==Administration== *Type: *Dosage Forms: *Routes of Administration: SC/IM, nasal *Common Trade Names: ==Adult Dosing== *Hypercalcemia: 4 IU/kg SC/IM q12hr ==Pediatric...")
(diff) ← Older revision | Latest revision (diff) | Newer revision → (diff)

Administration

  • Type:
  • Dosage Forms:
  • Routes of Administration: SC/IM, nasal
  • Common Trade Names:

Adult Dosing

Pediatric Dosing

Safety/efficacy not established

Special Populations

Pregnancy Rating

  • C

Lactation risk

Renal Dosing

  • Adult:
  • Pediatric:

Hepatic Dosing

  • Adult:
  • Pediatric:

Contraindications

  • Allergy to class/drug

Adverse Reactions

Serious

  • Malignancy risk increased in longterm use

Common

  • Rhinitis, epistaxis (intranasal)
  • Arthralgia, back pain
  • Injection site reaction
  • Nausea, abdominal pain, decreased appetite
  • Headache
  • Flushing
  • Allergic reaction
  • Edema of feet
  • Eye pain
  • Subjective fever
  • Nocturia
  • Salty taste

Pharmacology

  • Half-life: 43min[1]
  • Metabolism: Renal
  • Excretion: Urinary

Mechanism of Action

  • Inhibits osteoclastic bone resorption, decreases serum calcium, and increases renal excretion of phosphate, calcium, sodium magnesium and potassium by decreasing tubular reabsorption[2]


Comments

See Also

References

  1. ↑ https://reference.medscape.com/drug/fortical-miacalcin-calcitonin-salmon-342816#10
  2. ↑ https://reference.medscape.com/drug/fortical-miacalcin-calcitonin-salmon-342816#10
Retrieved from "https://www.wikem.org/w/index.php?title=Calcitonin&oldid=225727"
Authors: